Processa Pharmaceuticals, Inc. - PCSA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$328K
QoQ value delta ($000)
-$9K (-2.67%)
Implied price effect (QoQ)
+1404.97%
Shares
Total shares
115,174
QoQ shares delta
-1,665,727 (-93.53%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PCSA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 12 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
JANE STREET GROUP, LLC 86 30,190 0.0%
VANGUARD GROUP INC 67 23,586 0.0%
HRT FINANCIAL LP 56 19,691 0.0%
GEODE CAPITAL MANAGEMENT, LLC 44 15,323 0.0%
UBS Group AG 36 12,640 0.0%
Stonepine Capital Management, LLC 35 12,323 0.03%
Tower Research Capital LLC (TRC) 4 1,390 0.0%
BANK OF AMERICA CORP /DE/ 0 18 0.0%
WELLS FARGO & COMPANY/MN 0 6 0.0%
JONES FINANCIAL COMPANIES LLLP 0 7 0.0%